UTILEV

This brand name is authorized in Nigeria.

Active ingredients

The drug UTILEV contains one active pharmaceutical ingredient (API):

1	Levocetirizine UNII W69HSF2416 - LEVOCETIRIZINE HYDROCHLORIDE
	Levocetirizine, the (R) enantiomer of cetirizine, is a potent and selective antagonist of peripheral H1-receptors. Pharmacodynamic studies in healthy volunteers demonstrate that, at half the dose, levocetirizine has comparable activity to cetirizine, both in the skin and in the nose.
	Read more about Levocetirizine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5990	Syrup	Utilev Syrup SYRUP 5 mg/5 mL	50 Levocetirizine Hydrochloride 5 mg/5 mL Syrup B4-5990 Utilev Syrup Levocetirizine Hydrochloride, Sodium Chloride, Sodium, Methyl Hydroxybenzoate, Propylene Glycol, Sodium Propyl Hydroxybenzoate, Anhydrous Citric Acid, Disodium Edetate, Sweet Orange Flavour, Saccharin Sodium Antihistamines And Antiallergics Oral 5 mg/5ml Syrup Prescription Only Medicine (Pom) Healthline Limited M/S. Swiss Garnier Life Sciences India 2021-03-01 2026-02-28	01/03/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R06AE09	Levocetirizine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AE Piperazine derivatives
Discover more medicines within R06AE09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5990